Us News

Aligos Therapeutics announced a licensing deal with Xiamen Amoytop Biotech to develop and commercialize its hepatitis B drug candidate in Greater China.

After reporting declining revenue and mounting indebtedness, the parent company of the U.S. TV shopping network QVC said it would file for Chapter 11 at the US Bankruptcy Court for the Southern District of Texas.

Burry said he continues to hold Autodesk and Veeva Systems, and plans to take additional positions in Salesforce and MSCI.

The renewables fuel management company said that the loan conditions for the project were not commercially viable in the project area.

The brokerage added that the shift could allow the company to repurpose existing GLP-1 capacity toward other peptide treatments.

High-performance computing (HPC) accounted for 61% of total revenue.

The footwear maker’s sudden transformation into an AI infrastructure play sent shares soaring, but Wall Street sees more hype than substance so far.

On Wednesday, BIRD surged nearly 600%, while INTC rose 2% and MRVL gained 1%.

Slumping auto sales and weak investor sentiment may be offset by a new opportunity: helping replenish America's depleted weapons stockpiles.

Lam Research and Applied Materials benefit from rising wafer-fabrication equipment demand tied to AI infrastructure and high-bandwidth memory.

Microsoft recently shifted its AI strategy toward paid Copilot adoption and said it met “some pretty big audacious goals” for Copilot sales in the March quarter.

Fresh analyst cuts, delisting fears, and leadership uncertainty pushed all three stocks to 52-week lows despite pockets of retail optimism.

Wall Street momentum remained strong, with the Nasdaq logging its 11th straight gain and the S&P 500 rising in 10 of the past 11 sessions after recovering losses from the conflict earlier this week.

Lucid and Rivian are both looking to launch rival vehicles to Tesla’s Model Y before the end of the year priced under $50,000.

Health and Human Services Secretary Robert F. Kennedy Jr. said in an X post on Wednesday that the FDA will remove 12 peptides from the category of drug substances with significant safety risks.

SoFi Technologies shares have a 12-month average price target of $23.52 from Wall Street analysts, according to data from Koyfin, indicating an upside potential of about 25.20% from its last close.

The S&P 500 closed 0.8% higher, ending the session at 7,022.95, surging past a prior pre-war January high.

The agency is now slated to decide on the application by November 22, Savara said.

Despite these challenges, overall economic activity across the United States continued to grow at a slight to modest pace in most regions, the central bank noted in its report.

Treasury Secretary Scott Bessent said on Wednesday that the U.S. will not renew ​the waivers that allowed purchase of Iranian and ‌Russian oil.

According to data from Fiscal.ai, analysts on average expect the company to report year-over-year growth in both total revenue and earnings in the first quarter.

According to a report from The Wall Street Journal, citing people familiar with the matter, Sazerac offered Brown-Forman $32 a share.

In a regulatory filing, the Snapchat owner said it would be laying off about 1,000 employees, including 16% of its full-time employees.

Evercore ISI raised CoreWeave’s price target to $150 from $120 and maintained an ‘Outperform’ rating, after the company secured a $6 billion deal with Jane Street for the use of its AI cloud services.

Polaris’s arch-rival BRP Inc. suspended its fiscal year 2027 guidance on Tuesday.

The biotech firm said its Phase 2 trial of PDS01ADC showed a strong objective response rate and a 24-month survival rate.

Quantum stocks extended their rally on Wednesday over Nvidia’s recent launch of Ising, its open source quantum AI models, among other drivers.

Large banks and tech organizations have early access to Mythos, while crypto companies still rely on older AI models and internal security technologies.

If the move materializes, it would disrupt U.S. solar manufacturing plans and raise costs for companies dependent on Chinese technology.

The company secured a $50 million in financing to pivot to AI compute infrastructure.

Energous Corporation said its first Fortune 10 customer continues to deploy the company's infrastructure across 4,700 locations in the United States.

New board members bring experience from nuclear, energy, industrial, and infrastructure sectors.

The bank posted a 25% increase in diluted earnings per share to $1.11, well above the $1.02 Street estimate.

Immutep announced that the U.S. FDA granted Orphan Drug Designation for its drug for the treatment of soft-tissue sarcoma.

The company said it has closed all the legal proceedings with Knighted Pastures LLC.

The company will provide software solutions to Germany’s TKMS naval platforms.

The newly appointed CEO of the EV maker drew up plans to ‘channel the excitement’ and focus on the core business.

Tesla confirmed its next-generation AI5 chip has taped out, with volume production targeted for 2027.

The company recently said its EMJX AI hedging engine returned 5.69% in March, outperforming a 5% decline in the S&P 500.

Satellite communications expert Tim Farrar said Starlink would likely be loss-making if it paid full market rates for launches.

Uber has positioned itself as a marketplace for robotaxi operators and has partnered with multiple self-driving tech companies in the past decade.

The company’s BlueBird Block 2 launch slipped again this week to Saturday.

On Tuesday, WULF closed 8% higher, GSAT jumped 10%, and BE surged 24%.

Even though recent insider purchases provided a bump, NKE is heading for its worst year since 1997.

The S&P 500 closed within 1% of its Jan. 28 record high, marking its ninth gain in 10 sessions and a full recovery from earlier Iran conflict-driven losses.

The new rules allow brokers to monitor real-time exposure instead of restricting trading frequency.

While Hill bought nearly 24,000 shares of the company at a purchase price of $42.265/ share, Cook bought 25,000 shares of the company for $42.43/share.

The data center infrastructure operator closed the regular session up nearly 8% at $20.95, hitting a fresh 52-week high. In extended trading, the stock dropped as low as $19.12.

GitLab announced a deepened collaboration with Google Cloud on Tuesday.

Shkreli, widely nicknamed ‘pharma bro,’ said on Tuesday that progress is gradual in drug development.